Your search for smoking cessation returned 274 results

Study shows that all behavioral outcomes favor e-cigarette users across the motivational spectrum for quitting.

Cytisinicline well tolerated with only 2.9% of participants discontinuing due to an adverse event.

No significant difference in verified 7-day abstinence seen by treatment group among Black adults who smoke daily.

The Nicotrol Inhaler (nicotine inhalation system) has been discontinued by Pfizer.

The placebo-controlled ORCA-2 study evaluated the safety and efficacy of cytisinicline as a treatment for smoking cessation in 810 adult smokers.

N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.

Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.

The outpatient procedure provides noninvasive magnetic stimulation to areas of the brain known to be associated with addiction.

Guideline offers simple practice changes that may increase effectiveness of tobacco-dependence pharmacotherapy.

The Nonprescription Drugs Advisory Committee (NDAC) of the Food and Drug Administration (FDA) has recommended the approval of the New Drug Application (NDA) from GlaxoSmithKline for an over-the-counter (OTC) nicotine mouth spray to aid in smoking cessation (9 to 6 vote). The nicotine mouth spray (NMS) delivers 1mg nicotine per spray; each dispenser would deliver…